斯特拉提芬通过结合和过度激活AKT信号传导促进HCC的恶性进展
Rong Li1, Xijing Yan2, Wenhui Zhong3
1Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, 510630, China; Guangdong Province Engineering Laboratory for Transplantation Medicine, Organ Transplantation Research Center of Guangdong Province, Guangzhou, 510630, China.
斯特拉提芬 (SFN) 通过增加细胞增殖和瘤生长来驱动肝细胞癌 (HCC) 的进展. 准SFN/AKT通路为这种侵袭性肝癌提供了潜在的新疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝细胞癌 (HCC) 是一种具有不良预后的侵袭性肝癌.
- 有限的治疗选择需要了解HCC进展机制.
研究的目的:
- 调查斯特拉提芬 (SFN),也称为14-3-3σ在HCC发育中的作用.
- 阐明SFN在HCC中的功能背后的分子机制.
主要方法:
- 对HCC组织中SFN表达的分析和与患者结局的相关性.
- 在体外和体内实验中评估SFN对HCC细胞增殖,索拉芬尼布耐药性和瘤发生的影响.
- 研究SFN和AKT信号通路之间的相互作用.
主要成果:
- 在HCC组织中,SFN显著上调,并与患者预后更差有关.
- 过度表达SFN增强了HCC细胞的增殖,瘤发生,并降低了索拉芬尼的疗效.
- SFN静音可以逆转这些致癌效应.
- SFN与AKT相互作用,通过阻止PHLPP2结合来增加其激酶活性,从而促进HCC的进展.
结论:
- 在HCC进展中,SFN充当瘤基因.
- 在HCC中,SFN/AKT轴是关键的监管机制.
- 在HCC治疗中,SFN是潜在的治疗点.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
